ArticleMolecular medicine (Cambridge, Mass.)2012

Axitinib targeted cancer stemlike cells to enhance efficacy of chemotherapeutic drugs via inhibiting the drug transport function of ABCG2.

Fang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.